thymidine has been researched along with Brain Ventricular Neoplasms in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Four patients received 3H-thymidine 4 to 7 days and vinblastine 4 to 6 hours prior to operation for recurrent malignant gliomas (three glioblastomas and one anaplastic astrocytoma)." | 3.65 | Chemotherapeutic implications of growth fraction and cell cycle time in glioblastomas. ( Barker, M; Hoshino, T; Rosenblum, ML; Wilson, CB, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoshino, T | 1 |
| Wilson, CB | 1 |
| Rosenblum, ML | 1 |
| Barker, M | 1 |
1 other study available for thymidine and Brain Ventricular Neoplasms
| Article | Year |
|---|---|
Chemotherapeutic implications of growth fraction and cell cycle time in glioblastomas.
Topics: Biopsy; Cell Division; Cerebral Ventricle Neoplasms; Cerebral Ventricles; Glioma; Humans; Mitosis; M | 1975 |